Quadrant Biosciences Inc. faʻasalalau i aso nei o le United States Patent and Trademark Office (USPTO) ua tuʻuina atu le kamupani ma ana paaga, le SUNY Research Foundation ma le Penn State Research Foundation, US Patent Numera 11,242,563 (Analysis of Autism Spectrum Disorder). O le pateni e aofia ai le faavae faʻasaienisi mo le atinaʻeina o se fesoasoani faʻataʻitaʻi faʻavae, multiomic autism diagnostic aid, e mafai ona faʻaeseese ai tagata taʻitoʻatasi e iai le autism mai tagata taʻitoʻatasi o loʻo iai le atinaʻe masani poʻo le tuai o atinaʻe e ala i le fuaina o le microRNA (miRNA) ma le microbiome maualuga i le faua. Quadrant Biosciences, o se kamupani Life Science e faʻavae i Syracuse, Niu Ioka, faʻaogaina le faʻasologa o augatupulaga ma AI e atiaʻe ai suʻesuʻega mole mole RNA mo le tele o tulaga faʻafomaʻi.

"O le tuʻuina atu o se pateni aloaia a Amerika mo la matou galuega i le atinaʻeina o se fesoasoani faʻataʻitaʻi faʻavae mo autism o se faʻamaoniga manino o le fou ma le aoga o le auala na matou atiaeina," o le tala lea a Frank Middleton, PhD, Polofesa i SUNY Upstate Medical. Iunivesite ma se tasi o tagata suʻesuʻe autu i tua atu o suʻesuʻega pateni. "O la matou taulaiga i le faʻaogaina o se multiomic auala e tuʻufaʻatasia ai faʻatonuga RNA mai le tagata talimalo faʻapea foʻi ma le microbiome tautala ua maua ai le tele o malamalamaaga i le autism spectrum disorder."

O Dr. Steve Hicks, MD, PhD mai le Kolisi Fa'afomai a le Setete o Penn, o le isi tagata su'esu'e autu i luga o le pateni, na fa'amatalaina lona taua tele o le falema'i. "Matou te faʻamoemoe o lenei meafaigaluega mole mole o le a faʻaleleia atili ai le tomai o fomaʻi e iloagofie ai tamaiti i luga o le autism spectrum mai tupulaga e le o ni autistic le tuai o le atinaʻe, e mafai ai ona suʻesuʻeina muamua ma amata muamua le togafitiga o amioga. E le gata i lea, "na ia faaauau ai, "o lenei mataʻina e faʻamaonia ai le faʻafouina fou i le Quadrant Biosciences 'suʻesuʻega ma faʻalauteleina la matou sini tuʻufaʻatasia o le faʻaleleia o tausiga faʻafomaʻi mo tamaiti e maua i le autism spectrum disorder."

"Matou te fiafia ona ua tuʻuina mai e le USPTO la matou pateni mo lenei galuega suatia," o le tala lea a Rich Uhlig, Faʻavae ma Pule Sili o Quadrant Biosciences. "O lenei mea e lagolagoina ai a matou tausaga o taumafaiga malosi R&D e faʻamalamalamaina ai mea epigenetic e fesoʻotaʻi ma autism, ma atiaʻe tala fou faʻamaonia biomarkers e faʻafeiloaʻi ai le manaʻoga faʻanatinati e faʻapuupuu le autism diagnostic odyssey mo matua ma tagata tausi."

OA MEA E AVEA MAI LENEI TUSI:

“The issuing of an official US patent for our work on development of a saliva-based diagnostic aid for autism is a clear acknowledgement of the novelty and utility of the approach that we developed,”.
The patent covers the scientific foundation for the development of a saliva-based, multiomic autism diagnostic aid, that can differentiate individuals with autism from individuals with typical development or developmental delays by measuring microRNA (miRNA) and microbiome levels in saliva.
“This supports our years of rigorous R&D efforts to illuminate the epigenetic factors associated with autism, and develop novel diagnostic biomarkers to address the urgent need to shorten the protracted autism diagnostic odyssey for parents and caregivers.